Post date: 2017
Her research seeks to identify optimal treatments for the rehabilitation of balance impairments using neuromechanical approaches
Xia lab gives LDL particles an interior upgrade to improve drug delivery
Scientists have examined an active nematic built with components borrowed from living cells.
Petit Institute’s Todd Sulchek part of research team to win new seed grant
Georgia Tech leading the effort to develop manufacturing expertise and expand cell therapies
CauteryGuard among six teams vying for $20,000 top prize
A profile of 10 female roboticists
BME grad student will study cutting edge imaging technique at University of Lausanne in Switzerland
Post date: 2018
A mechanism tries to stop our T cells from causing autoimmune disorders, and it's like a tight handshake that kills overly aggressive T cells.
National thought leaders help high school program celebrate seniors at Petit Institute
Klingenstein-Simons fellowship will help Simon Sponberg reveal how neural systems organize for sophisticated behaviors like flight.
New role will enable NIH to fund essential, cutting-edge biomedical research
New group of undergrad researchers represents future of bioengineering and bioscience leadership
Engineers are developing methods for decoding the conversation
Post date: 2016
A bacterial warrior the only one of its kind? This enzyme is "wacko" in the ways it breaks down a poison related to TNT.
Nine graduate students launch Georgia Tech’s third interdisciplinary life sciences Ph.D.
Techniques Symposium offers wide-ranging ‘shotgun approach’ for young researchers
The Georgia Institute of Technology will play a key role in a new federally backed initiative to advance medications made from cells, such as vaccines and autoimmune drugs, as well as therapies using living cells to treat a range of conditions.
Post date: 2019
Georgia Institute of Technology President G.P. “Bud” Peterson today announced he will retire as president in the summer of 2019, a position he’s served in since 2009.
A team of researchers at the Georgia Institute of Technology has kicked off a three-year federally-funded project to harness new manufacturing technologies and methods in a bid to bring down the cost of making certain antibiotics.